more_reports

The Latest Medical Devices Articles from Streetwise Reports

Clean Tech Co.'s 'Forever Chemical' Solution Is a PFAS Breakthrough

  ()
Clean technology company BioLargo Inc. (BLGO:OTCQX) announced compelling new findings about its proprietary Aqueous Electrostatic Concentration (AEC) "forever chemicals" solution. Read to discover why one expert thinks the breakthrough is important to the company's future.
Tags: Alternative - CleantechMedical DevicesAlternative EnergyHealthcare ServicesBattery Metals

Medical Co.'s New Joint Venture Could Expand Co.'s Footprint

Research Report
  ()
Leede Financial Inc. analyst Dr. Douglas Loe gave this company a Buy rating.
Tags: Medical Devices

Cleantech/Life Sciences Co. Advances Products in Q2/25

Research Report
  ()
BioLargo Inc. (BLGO:OTCQX) enters into several agreements, forms partnerships and receives third party product validation, noted an Oak Ridge Financial report.
Tags: Alternative - CleantechMedical Devices

Biotech Enters Agreement with Co. Behind Tegoprubart

Research Report
  ()
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) likely will use this new monoclonal antibody as an immunosuppressant in its Phase 1/2 trial's Cohort C instead of previously used tacrolimus, noted an H.C. Wainwright & Co. report.
Tags: Regenerative MedicineMedical Devices

Biotech Boasts Compelling Pipeline

Research Report
  ()
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) is exploring financing options with some potential sources of capital, noted a Research Capital Corp. report.
Tags: Medical Devices

Analyst Shares Thoughts After Microdisplay Co.'s Demo Day

Research Report
  ()
Kopin Corp.'s (KOPN:NASDAQ) display and optical technologies as well as its products are impressive, noted a Lake Street Capital Markets report.
Tags: TechnologyMedical Devices

Interim Data From TID Trial Are Positive

  ()
Sernova Biotherapeutics Inc.'s (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) regenerative treatment delivered via its Cell Pouch Bio-hybrid Organ is proving to result in insulin independence, among other outcomes. Read what one analyst says are the implications of this clear medical benefit.
Tags: Regenerative MedicineMedical Devices

One Co. With Cell Holding Device Stands Out in T1D Space

Research Report
  ()
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) alone has shown favorable outcomes in a trial when patients with this disease were treated with an implanted device containing donor islets, noted an H.C. Wainwright & Co. report.
Tags: Medical DevicesRegenerative Medicine

Showing Results: 1 to 8 of 8